NCT05243888View on ClinicalTrials.gov

Efficacy of Strategies Involving Self-sampling to Reach Women Not Participating in Regular Cervical Cancer Screening

NAActive, not recruitingINTERVENTIONAL
Enrollment

15,000

Participants

Timeline

Start Date

March 9, 2022

Primary Completion Date

August 31, 2023

Study Completion Date

March 31, 2025

Conditions
Cancer Screening Test
Interventions
DIAGNOSTIC_TEST

self-sampling

eligible women receive at their home address a self-sampling kit in addition to the conventional invitation letter

Trial Locations (1)

Unknown

CRCDC Pays de la Loire, Angers

All Listed Sponsors
collaborator

National Cancer Institute, France

OTHER_GOV

collaborator

Sciensano

OTHER_GOV

collaborator

University Hospital, Angers

OTHER_GOV

collaborator

University of Angers

UNKNOWN

lead

Centre Regional de Coordination des Depistages des Cancer - Pays de la Loire

OTHER